- Home
- NXJ vs LAB Comparison
NXJ vs LAB Comparison
Compare NXJ & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXJ
- LAB
- Stock Information
- Founded
- NXJ 1999
- LAB 1999
- Country
- NXJ United States
- LAB United States
- Employees
- NXJ N/A
- LAB N/A
- Industry
- NXJ Finance/Investors Services
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- NXJ Finance
- LAB Industrials
- Exchange
- NXJ Nasdaq
- LAB Nasdaq
- Market Cap
- NXJ 457.7M
- LAB 473.2M
- IPO Year
- NXJ N/A
- LAB 2011
- Fundamental
- Price
- NXJ $11.29
- LAB $1.27
- Analyst Decision
- NXJ
- LAB Buy
- Analyst Count
- NXJ 0
- LAB 2
- Target Price
- NXJ N/A
- LAB $2.50
- AVG Volume (30 Days)
- NXJ 74.9K
- LAB 1.2M
- Earning Date
- NXJ 01-01-0001
- LAB 08-11-2025
- Dividend Yield
- NXJ 3.27%
- LAB N/A
- EPS Growth
- NXJ N/A
- LAB N/A
- EPS
- NXJ N/A
- LAB N/A
- Revenue
- NXJ N/A
- LAB $172,271,000.00
- Revenue This Year
- NXJ N/A
- LAB N/A
- Revenue Next Year
- NXJ N/A
- LAB $12.18
- P/E Ratio
- NXJ N/A
- LAB N/A
- Revenue Growth
- NXJ N/A
- LAB 76.33
- 52 Week Low
- NXJ $10.06
- LAB $0.92
- 52 Week High
- NXJ $12.24
- LAB $2.32
- Technical
- Relative Strength Index (RSI)
- NXJ 49.30
- LAB 49.23
- Support Level
- NXJ $11.12
- LAB $1.15
- Resistance Level
- NXJ $11.52
- LAB $1.32
- Average True Range (ATR)
- NXJ 0.09
- LAB 0.07
- MACD
- NXJ -0.01
- LAB -0.01
- Stochastic Oscillator
- NXJ 42.50
- LAB 54.55
About NXJ Nuveen New Jersey Qualified Municipal Fund
Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The company invests a majority of its managed assets in securities rated, at the time of investment, investment grade or, if the bonds are unrated, are judged by the manager to be of comparable quality.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.